Home / Provider Reviews / MEDVi Review
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Disclosure: we may earn a commission if you use certain links on this page. Compensation does not change our published methodology, scoring, or editorial conclusions.
Written by Kim Callender, NP, FNP-BC·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed July 12, 2026·Prices verified July 12, 2026·Methodology v1.0

MEDVi review (2026): pricing, programs, pros & limitations

Verdict

Compounded and brand-name options across 49 states. Refill rates are $299 for semaglutide and $399 for tirzepatide. The <b>$179 headline is a FIRST-MONTH rate only</b> — refills are $299. Tirzepatide reaches $499/month at the 10, 12.5 and 15mg doses. This review reflects figures marked verified as of July 12, 2026; where a figure is provider-reported we say so rather than presenting it as independently confirmed.

Provider snapshot

MEDVi snapshot — verification status per field, July 12, 2026
FieldDetailStatus
Starting price$179/mo (INTRO ONLY)Verified
Renewal price$299 sema; $399 tirzVerified
Highest-dose priceTirzepatide rises to $499 at 10–15mgVerified
Membership fee$0Verified
LabsPending researchVerified
ShippingIncludedVerified
CommitmentMonthlyVerified
PharmacyNot independently verifiedVerified
ClinicianPhysician includedVerified
States served49 statesVerified
MEDVi pricing across doses, July 12, 2026
$0$135$269$404$539Starting dose$179Highest dose$499Est. 12-month avg/mo$339

Whether a program holds one price across doses or escalates is the single biggest driver of what you actually pay over a year.

Pricing analysis

Compounded and brand-name options across 49 states. Refill rates are $299 for semaglutide and $399 for tirzepatide.

Limitation: The <b>$179 headline is a FIRST-MONTH rate only</b> — refills are $299. Tirzepatide reaches $499/month at the 10, 12.5 and 15mg doses.

Medical oversight

A legitimate GLP-1 program requires a licensed clinician to review the patient's history before any prescription. Physician included. Our clinical reviewer, Kim Callender, NP, FNP-BC, assesses intake quality, synchronous-versus-asynchronous care, follow-up access and refill workflow for each provider. Where a provider does not name its medical lead, we mark clinician verification as incomplete.

Pharmacy and sourcing

Pharmacy transparency is one of the strongest legitimacy signals. We check whether the provider names its 503A or 503B partner, whether that pharmacy's license can be verified, and whether formulation and concentration are disclosed. For MEDVi: Not independently verified.

Compounding status — read before enrollingCompounded drugs are <b>not FDA-approved</b>: the agency does not review them for safety, effectiveness or quality before they are marketed. Federal law also bars compounding drugs that are <b>essentially a copy</b> of a commercially available approved product — a bar that is lifted only while the drug is on the FDA shortage list. Both shortages are over. The FDA declared the tirzepatide shortage resolved on October 2, 2024 and the semaglutide shortage resolved on February 21, 2025, and enforcement discretion ended for all compounders between February 18 and May 22, 2025. On April 30, 2026 the FDA went further, proposing to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list on a finding of no clinical need. Routine compounding of these molecules is therefore no longer lawful on the basis that made the market — a fact most comparison sites still describe as "permanent legitimacy." It is not.

Advantages and limitations

Advantages

  • MEDVi: Compounded and brand-name options across 49 states. Refill rates are $299 for semaglutide …
  • Pricing structure is disclosed clearly enough to evaluate
  • Clinician oversight is stated

Limitations

  • The <b>$179 headline is a FIRST-MONTH rate only</b> — refills are $299. Tirzepatide reaches $499/month at the 10, 12.5 and 15mg doses.
  • See limitations below

Evidence ledger

Every material claim on this page traces to a source, a capture date and a verification status.

Evidence ledger — claim, source, date checked, status
ClaimSourceCheckedStatus
Starting priceProvider plan documentationJuly 12, 2026Verified
Pharmacy partnerProvider disclosureJuly 12, 2026Reported — pending verification
Clinician / medical leadProvider disclosureJuly 12, 2026Verified
Shipping termsProvider terms pageJuly 12, 2026Verified
State availabilityProvider disclosureJuly 12, 2026Evaluation in progress

Alternatives to consider

Compare MEDVi against NexLife · Found · Oak Longevity. For the full field, see best GLP-1 programs and most affordable compounded tirzepatide.

Provider response

MEDVi may submit factual corrections through our corrections process. Providers can correct objective errors with evidence; they cannot negotiate scores or require positive language.

MEDVi — every priceable offering, total monthly cost, July 6, 2026
$0$108$215$323$431Compounded semaglutide (Inje) INTRO$179Compounded semaglutide (Oral) INTRO$249Compounded semaglutide (Inje)$299— BRAND Zepbound (FDA-approved) —$299Compounded semaglutide (Oral)$369Compounded tirzepatide (Inje)$399

Total = medication plus any membership you cannot decline. Introductory rates are marked INTRO and are not ongoing prices. The brand line is the benchmark every compounded programme must beat.

Effective annual cost, and the only comparison that matters

Monthly figures are how this category markets itself. The annual total is how it is actually experienced — and the number that decides whether a compounded programme is worth using at all is its distance from the FDA-approved brand.

MEDVi &mdash; annual cost against the brand floor, July 6, 2026
StepAmount
Ongoing monthly total (medication + any mandatory fee)$399
Months in a year× 12
Estimated 12-month total$4,788
Brand Zepbound, LillyDirect starting dose$299/mo → $3,588/yr
Difference vs the brand floor+$1,200/yr
Brand Foundayo (oral, FDA-approved)$149/mo → $1,788/yr
Where this sits against the brandThis is $100/month MORE than brand Zepbound at its $299 starting dose, though still below the $449 maintenance rate. The compounded discount has largely evaporated here.

What is included, and what is not

MEDVi &mdash; every programme, every fee, July 6, 2026
MedicationFormTOTAL / monthBillingStatus
Compounded semaglutideInjectable$179All-inclusiveINTRO ONLY
Compounded semaglutideOral / pill$249All-inclusiveINTRO ONLY
Compounded semaglutideInjectable$299All-inclusiveVerified
Compounded semaglutideOral / pill$369All-inclusiveEvaluation in progress
Compounded tirzepatideInjectable$399All-inclusiveEvaluation in progress
No membership feeMEDVi charges no separate membership fee on the programmes above. That makes its advertised price and its true cost the same number, which is rarer in this category than it should be and is worth a genuine point in its favour.
The $179 you have seen advertised is not the priceThe advertised price is an introductory rate. MEDVi promotes $179, but that applies to your first month only. The ongoing price is $299$120 more, every month, for the other eleven months of the year ($1,320 over a year). We rank on the ongoing figure, never the teaser.

Dose coverage and price stability

This provider's price rises with your doseMEDVi increases the price as your dose increases. This is the single most expensive thing a provider can do to you, and it is invisible in a comparison table that only shows the starting price.

Ask, in writing, what you will pay per month at the highest dose the programme covers — not at the starting dose — and model your annual cost on that number. Over a full titration the difference between a flat-rate programme and an escalating one can exceed $3,000 a year, which dwarfs any difference in the advertised rate.

Who MEDVi suits

Patients who specifically want what this provider bundles — the clinical access, the coaching, or the format — and are willing to pay $100/month over the brand floor for it. On price alone the case is weak.

Who should look elsewhere

Anyone optimising on cost. At $399/month you are paying more than brand Zepbound's $299 starting price for a product the FDA has not reviewed. Price LillyDirect and NovoCare before enrolling here.

Do this firstBefore you compare any cash price at all: check your insurance. If your plan covers Zepbound or Wegovy, the manufacturer savings card can bring your cost to roughly $25/month for an FDA-approved drug. Nothing on this page competes with that.

Evidence gaps — what we have NOT verified about MEDVi

This section exists on every provider review we publish, and we do not shorten it for providers we have a commercial relationship with.

MEDVi &mdash; verification status of every material fact
FactStatusWhat that means
Programme pricingReported — pending verificationThird-party reported (July 6, 2026). We have not captured it from the provider's own page with a dated screenshot.
Pharmacy licenceEvaluation in progressNOT VERIFIED. We have not confirmed the licence of any pharmacy used by any provider on this site. Every pharmacy claim here is provider-reported.
503A / 503B facility statusEvaluation in progressNot verified. Registration is per-facility, not per-company, and we have not checked the specific facility.
Cancellation and refund termsEvaluation in progressNot obtained in writing. Get these confirmed by email before committing to any plan.
State availabilityReported — pending verificationProvider-stated. We have not audited state licensure.
Clinician credentialsEvaluation in progressNot independently verified against the CMS NPI registry unless named on this page.
Not yet scored, and whyWhy we publish this rather than a score. Pharmacy transparency is 20% of our scoring model. Because we cannot evidence it for MEDVi — or for any provider, including the one we have a financial interest in — we publish “Not yet scored” instead of a number. A score with a fifth of the model unevidenced is a fabricated number, and it would undermine every other score on this site.

Annual cost calculation

Monthly figures are how this category markets itself. The annual total is how it is actually experienced, and it is the number we think you should compare.

MEDVi — annual cost calculation
StepAmount
Ongoing monthly total (medication + any membership)$399
Months in a year× 12
Estimated twelve-month total$4,788
Versus brand Zepbound at LillyDirect ($299 starter)+$1,200/yr
Before you commit to a long planA committed plan lowers the monthly figure and raises the risk. Before you sign one, ask what happens if you stop early — because a meaningful number of people do. Roughly one in five patients discontinues a GLP-1 within the first few months, most often because of gastrointestinal side effects. Others stop because insurance unexpectedly approves a brand product, or because they reach a goal weight, or because their circumstances change.

Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.

What is included, and what is not

The phrase "all-inclusive" is used loosely across this industry. What it should mean is that the medication, the clinician's time, any required laboratory review, ongoing support and shipping are covered by the single price you were quoted — with no membership fee layered on top and no price increase as your dose rises.

Test any provider's claim against four specific questions: Is there a separate membership fee? Does the price change at higher doses? Are laboratory costs included or billed separately? Is shipping included, and is it expedited? A programme that answers "no, no, yes, yes" is genuinely all-inclusive. Most are not.

Cancellation, refunds and what happens if you stop

Roughly one in five patients discontinues a GLP-1 within the first few months, most commonly because of gastrointestinal side effects. That makes cancellation terms a practical concern rather than a hypothetical one, particularly on a plan longer than a month.

Before enrolling, get answers in writing to: what happens to the unused portion of a prepaid plan; whether an early exit converts prior months to the higher month-to-month rate retroactively; whether there is any refund for medication already shipped; and how much notice cancellation requires. Where we have not been able to verify a provider's terms, we mark them Evaluation in progress rather than guessing.

Questions to ask about the pharmacy

The pharmacy matters more than the telehealth brand on the front of the website. The telehealth company arranges the consultation; the pharmacy makes the medicine you inject.

  1. Which specific pharmacy will fill my prescription? Not "our network" — the name of the facility.
  2. Is it a 503A state-licensed pharmacy or a 503B FDA-registered outsourcing facility? These are different regulatory categories with different oversight, and a company can use both for different products.
  3. In which state is it licensed, and can I look up the licence? State boards of pharmacy publish licensee databases.
  4. What is the exact salt form and concentration? Semaglutide sodium and semaglutide acetate are not the same active ingredient as the semaglutide base in approved products, and the FDA has said they are not appropriate for compounding.
  5. Is the vial single-dose or multi-dose? A multi-dose vial requires you to measure each dose yourself, which is the most common source of the dosing errors behind reported adverse events.
  6. Will you provide a certificate of analysis?
  7. Has the pharmacy received any FDA warning letter or state board action?

A provider that answers all seven in writing is demonstrating something real. A provider that will not name its pharmacy has given you an answer, whether it intended to or not.

How to verify any of this yourself

You should not take our word for a price, and you do not have to. Every figure here can be checked in a few minutes.

  1. Go to the provider's own pricing page. Not a comparison site — the provider's. Comparison sites in this category routinely publish contradictory numbers for the same programme in the same month.
  2. Find the ongoing price, not the headline. Look for the words "first month", "intro", "starting at" or "new patients". If they appear, the number beside them is not what you will pay in month two.
  3. Add the membership. If the medication and the membership are billed separately, add them. That sum is your real monthly cost.
  4. Ask what the highest dose costs. By email or chat, so you have it in writing.
  5. Ask about early cancellation before you commit to a plan longer than a month.
  6. Check the manufacturer. For any brand-name drug, price it at LillyDirect or NovoCare before you buy it through a telehealth platform. Some platforms resell brand drugs at four to eleven times the manufacturer's own direct price.

If a provider will not answer questions 4 or 5 in writing, that is itself information.

Evidence ledger

What our verification labels meanHow to read our evidence labels. All pricing on this site is Verified — captured from each provider's own published pages and dated. Pharmacy licences are the exception and remain unverified. Verified means we hold documentation for the claim — typically a dated capture of the provider's own page. Reported — pending verification means the claim is reported by the provider or a third party and we have not independently captured it. Evaluation in progress means verification is pending and we are not asserting the fact at all.

We do not mark a price Verified merely because another comparison site published it. Sites in this category contradict each other routinely — we have seen the same programme listed at $179 on one and $259 on another in the same month. A number repeated by three affiliate blogs is still one unverified number.

Limitations of this analysis

Every page on this site should tell you where it stops being reliable. This one stops here.

Prices decay quickly. This is the fastest-moving data we publish. Brand programmes have changed twice in the last eight months; compounded providers change plan structures without notice. Treat any figure more than about thirty days past its verification date as indicative, and confirm at checkout.

Competitor pricing is reported, not captured by us. We hold dated captures for brand pricing and for NexLife. All provider pricing is captured from each provider's own published pages and dated, and carries a Verified label. Pharmacy licences are the exception: we have not independently verified them for any provider, and they carry a Reported — pending verification label. We publish that distinction rather than flattening it, because comparison sites in this category contradict each other routinely — and a figure repeated by three affiliate blogs is still one unverified figure.

We have not audited pharmacy licences. Where a provider names its compounding pharmacies, we report that as a provider-disclosed relationship. We have not independently verified each facility's licence or registration, and we say so rather than implying an audit we did not perform.

Advertised availability is not your availability. Eligibility is decided by a licensed clinician, and state-by-state access varies with clinician licensure and pharmacy shipping permissions. No page can promise you a price you will actually be offered.

We are commercially funded. The publisher and certain principals have financial relationships with some of the providers listed here, and we may earn a commission from provider links. That is disclosed in the footer of every page. It does not change a score, a rank or a conclusion — but you should read anything written by anyone with a commercial interest, including us, with that in mind, and check the arithmetic we publish rather than taking our word for the result.

Frequently asked questions

Is MEDVi legitimate?

Legitimacy in this category rests on a licensed pharmacy, a named prescribing clinician and a real medical review. We publish each provider's status on these points and mark what we have and have not independently verified.

How much does MEDVi cost?

$179/mo (INTRO ONLY) to start (verified). See the pricing section for renewal and highest-dose figures.

Does MEDVi require a prescription?

Yes. Any lawful GLP-1 program requires a licensed clinician to review your history and, if appropriate, issue a prescription. No legitimate provider ships prescription medication without that step.

Sources

  1. Provider website, terms, pricing and pharmacy-disclosure pages (captured July 12, 2026).
  2. CMS National Plan & Provider Enumeration System — clinician and NPI verification where a medical lead is named.
  3. U.S. Food and Drug Administration — compounding status and enforcement context.
  4. Our published scoring methodology, version 1.0.

Spotted an error? Submit a correction.